At recent prices, you can buy shares of Merck (NYSE: MRK) that offer a yield above 3%, and shares of Pfizer (NYSE: PFE) offer ...
Pfizer faces stagnant revenue and patent cliffs. Learn why I downgraded PFE stock to Strong Sell despite a 24.7% YoY growth ...
Pfizer faces revenue decline from patent expirations, profitability challenges, and bearish technicals. Learn why PFE stock ...
Jefferies analyst Akash Tewari increased the price target for Pfizer (NYSE:PFE) shares from $33.00 to $34.00, while ...
Pfizer (PFE) stock is up today after the pharmaceutical company reported earnings for the fourth quarter of 2024. The company ...
Pfizer Inc. (NYSE:PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
CNBC on MSN8d
Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay offThe results cap off a critical year for Pfizer, which has been slashing costs as it recovers from the rapid decline of its ...
Pfizer offers a more diverse revenue stream ... see from the well-established pharmaceutical giant. At recent prices, the stock offers a 3.7% yield. Last March, the Food and Drug Administration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback